C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2002
11/12/2002	US6479266 IKK-α proteins nucleic acids and methods
11/12/2002	US6479264 Reversible inactivation enzymes
11/12/2002	US6479263 Method for detection of micrometastatic prostate cancer
11/12/2002	US6479258 Non-stochastic generation of genetic vaccines
11/12/2002	US6479254 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents
11/12/2002	US6479251 Colorimetric test for agents that induce mitochondrial dysfunction
11/12/2002	US6479250 Eck receptor ligands
11/12/2002	US6479249 Method of determining cholesterol content of high-density lipoproteins
11/12/2002	US6479247 Antibody for use in the treatment of cancer and arthritis
11/12/2002	US6479244 Method for genotyping microsatellite DNA markers
11/12/2002	US6479243 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
11/12/2002	US6479242 Method for genotyping of single nucleotide polymorphism
11/12/2002	US6479241 High throughput screening of the effects of anti-cancer agents on expression of cancer related genes in various cell lines
11/12/2002	US6479240 Electrodes linked via conductive oligomers to nucleic acids
11/12/2002	US6479239 Detection and characterization of microorganisms
11/12/2002	US6479238 Polymorphic markers of the LSR gene
11/12/2002	US6479237 Methods for detecting interaction among several proteins
11/12/2002	US6479236 Nucleotide sequences coding enzymatic polypeptide for use in drug screening
11/12/2002	US6479235 Multiplex amplification of short tandem repeat loci
11/12/2002	US6479234 Detection of hypermutable nucleic acid sequence in tissue and body fluids
11/12/2002	US6479233 Electrogenerated chemiluminescence labels for analysis and/or referencing
11/12/2002	US6479064 Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
11/12/2002	US6479051 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
11/12/2002	US6479015 Apparatus for monitoring a level of a chemical species in a body fluid
11/12/2002	US6478939 Biosensor device and method
11/12/2002	US6478938 Electrochemical membrane strip biosensor
11/12/2002	CA2214400C Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid
11/12/2002	CA2170515C Nucleotide sequences for novel protein tyrosine phosphatases
11/12/2002	CA2116576C Nucleic acid polymerase amplification
11/12/2002	CA2088917C Therapeutic ribozyme compositions
11/10/2002	CA2382463A1 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/08/2002	CA2385212A1 Method for direct measurement of coagulation factor viia activity in plasma
11/07/2002	WO2002089498A2 Selection method
11/07/2002	WO2002088753A1 Individualization of therapy with erectile dysfunction agents
11/07/2002	WO2002088750A2 Proteins, genes and their use for diagnosis and treatment of breast cancer
11/07/2002	WO2002088736A2 Prenatal diagnosis method on isolated foetal cell of maternal blood
11/07/2002	WO2002088714A2 Individualization of therapy with antineoplastic agents
11/07/2002	WO2002088686A1 Waveguide and assay
11/07/2002	WO2002088396A2 Reagents and methods for automated in situ or microarray hybridization
11/07/2002	WO2002088394A1 Method for identifying and genotyping microorganisms
11/07/2002	WO2002088390A1 Method and kit for diagnosing gh deficiency
11/07/2002	WO2002088389A1 Nonspecific hybridization inhibitors, clinical examination reagents and clinical examination method
11/07/2002	WO2002088388A1 A method and a device for quantification of mutation loads
11/07/2002	WO2002088387A2 Amplification process
11/07/2002	WO2002088386A2 Nasba-based detection of fungi
11/07/2002	WO2002088385A1 Method of nucleic acid sequence detection using general primers and the related kits
11/07/2002	WO2002088384A1 Screening method
11/07/2002	WO2002088383A2 Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
11/07/2002	WO2002088382A2 Method for analysing nucleic acid chains
11/07/2002	WO2002088381A2 Method for determining gene expression
11/07/2002	WO2002088379A2 Methods and compositions for utilizing changes of hybridization signals during approach to equilibrium
11/07/2002	WO2002088369A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/07/2002	WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002	WO2002088363A2 Regulation of novel human prolyl 4-hydroxylases
11/07/2002	WO2002088362A2 Regulation of human prostaglandin-f synthase 1-like protein
11/07/2002	WO2002088349A1 Method of examining allergic disease using cathepsin-c alternative splicing form as indication
11/07/2002	WO2002088343A2 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT)
11/07/2002	WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002	WO2002088335A1 Stem cells and method of separating the same
11/07/2002	WO2002088325A2 Vector system for selection of genes encoding secreted proteins and membrane-bound proteins
11/07/2002	WO2002088324A2 Methods for determining secondary modifications of molecules using arrays
11/07/2002	WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088314A2 Ovary-specific genes and proteins
11/07/2002	WO2002088309A2 Fusion genes associated with acute megakaryoblastic leukemias
11/07/2002	WO2002088305A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
11/07/2002	WO2002088300A1 Use of a miniature device for separating and isolating biological objects and methods used
11/07/2002	WO2002088299A1 Miniature device for separating and isolating biological objects and uses thereof
11/07/2002	WO2002088296A1 Multichamber device and uses thereof for processing of biological samples
11/07/2002	WO2002088184A1 A molecular marker
11/07/2002	WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002	WO2002088171A2 Combinatorial libraries of monomer domains
11/07/2002	WO2002088168A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
11/07/2002	WO2002088165A1 Elucidation of gene function
11/07/2002	WO2002088163A1 Antisense modulation of interferon gamma receptor 2 expression
11/07/2002	WO2002088160A1 Immobilization of oligonucleotides onto solid supports
11/07/2002	WO2002088081A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
11/07/2002	WO2002088078A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
11/07/2002	WO2002087792A1 Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles
11/07/2002	WO2002087761A1 Method for accelaration and intensification of target-receptor binding and devices therefor
11/07/2002	WO2002087632A1 High throughput screening methods using magnetic resonance imaging agents
11/07/2002	WO2002087606A2 Modulators of the hypocretin system and methods of screening therefor
11/07/2002	WO2002087589A1 Medicine for inhibiting drug elimination pump
11/07/2002	WO2002087554A2 Ef-tu binding agent as antibacterial agent
11/07/2002	WO2002087530A1 Tyrosinase assay
11/07/2002	WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002	WO2002087499A2 Cells for detection of enteroviruses
11/07/2002	WO2002087419A2 Biological pacemaker
11/07/2002	WO2002075022A8 Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration
11/07/2002	WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002	WO2002069890A3 Methods of identifying agents affecting atrophy and hypertrophy
11/07/2002	WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002	WO2002062950A3 Method for quantification of recombinant viruses
11/07/2002	WO2002059271A3 Gene expression profiles in breast tissue
11/07/2002	WO2002052016A3 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
11/07/2002	WO2002042492A3 Method for detecting protozoae of the genus naegleria
11/07/2002	WO2002040699A3 Sampling and storage system for genetic material from tissue
11/07/2002	WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002	WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002	WO2002037077A3 Screening methods based on transcriptional regulation analysis system using transformed cell lines

1 ... 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 ... 3003